This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Patrick Hsu, Ph.D.
Co-Founder, Arc Institute and Associate Professor at UC Berkeley


Patrick Hsu is Co-Founder and a Core Investigator of the Arc Institute and Assistant Professor of Bioengineering and Deb Faculty Fellow at the University of California, Berkeley. A pioneer in the field of CRISPR gene editing, Patrick’s work aims to accelerate scientific progress through innovation in biotechnology development, science funding, and research organizations. His research group works at the intersection of synthetic biology, genetics, and AI to invent new biotechnologies for improving human health, recently reporting inventions for programmable RNA perturbation in living cells, ‘gene writing’ with DNA integrases, and point-of-care diagnostic tests. Patrick received A.M. and Ph.D. degrees from Harvard University and his research has been recognized by the NIH Early Independence Award, the MIT Technology Review’s Innovators Under 35, the Rainwater Prize for Innovative Early Career Scientists, and the Amgen Young Investigator Award.

Agenda Sessions

  • Discovery of a Unified RNA-guided Mechanism for Programmable Genome Manipulation